Medlab Clinical Stock Price, News & Analysis (ASX:MDC)

0.00 (0.00 %)
(As of 09/20/2019 04:00 PM ET)
Today's Range
Now: A$0.46
50-Day Range
MA: A$0.46
52-Week Range
Now: A$0.46
Volume33,290 shs
Average VolumeN/A
Market Capitalization$99.07 million
P/E RatioN/A
Dividend YieldN/A
Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Phone61 2 8188 0311



Sales & Book Value

Annual Sales$5.43 million
Cash FlowA$0.05 per share
Book ValueA$0.07 per share



Market Cap$99.07 million
Next Earnings DateN/A

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

Medlab Clinical (ASX:MDC) Frequently Asked Questions

What is Medlab Clinical's stock symbol?

Medlab Clinical trades on the ASX under the ticker symbol "MDC."

Has Medlab Clinical been receiving favorable news coverage?

News headlines about MDC stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medlab Clinical earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Medlab Clinical.

Who are some of Medlab Clinical's key competitors?

Who are Medlab Clinical's key executives?

Medlab Clinical's management team includes the folowing people:
  • Dr. Sean Michael Hall, MD, CEO & Director
  • Mr. Alan Dworkin, CFO & Company Sec.
  • Dr. Luis Vitetta BSc(Hons), Grad Dip, Ph.D., Grad Dip Nutr, Director of Medical Research
  • Dr. David A. Rutolo, Director of Science
  • Mr. Paul Vilner, Director of Commercial Operations

What is Medlab Clinical's stock price today?

One share of MDC stock can currently be purchased for approximately A$0.46.

How big of a company is Medlab Clinical?

Medlab Clinical has a market capitalization of $99.07 million and generates $5.43 million in revenue each year. View Additional Information About Medlab Clinical.

What is Medlab Clinical's official website?

The official website for Medlab Clinical is

How can I contact Medlab Clinical?

The company can be reached via phone at 61 2 8188 0311.

MarketBeat Community Rating for Medlab Clinical (ASX MDC)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  5 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  7
MarketBeat's community ratings are surveys of what our community members think about Medlab Clinical and other stocks. Vote "Outperform" if you believe MDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel